GHP (Global Health and Pharma) is a global information sharing platform for life science and pharmaceutical professionals. “Here at GHP we love to recognize and honour companies for their hard work and dedication to their sector of work within the global health and pharmaceutical industry”, comments Stephanie Smith, Features Executive, GHP Magazine.
“We appreciate this award. Today the most important thing for us is to work together with the whole industry to maintain the highest clinical research standards. We are always ready to assist our partners from all over the world with our dynamic expert team to make projects the most efficient and productive as possible”, says Dmitry Sharov, OCT President.
The GHP research team takes into consideration customer satisfaction, previous awards and nominations, the past year’s achievements, experience, industry expert opinion, and many other factors to determine placement in the rankings.
By now the OCT team has successfully completed more than 240 clinical trials in Europe and the US. The company was named the top CRO with the highest number of clinical and BE study approvals obtained in 2016.